Drug Profile
Daunorubicin - SuperGen
Alternative Names: DaunoExtraLatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator SuperGen
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Leukaemia
Most Recent Events
- 20 Jul 2001 This compound is still in active development
- 24 Aug 2000 Investigation in Leukaemia in USA (Parenteral)
- 08 May 1998 Preclinical development for Leukaemia in USA (Parenteral)